HSBC Holdings
RCKT icon

HSBC Holdings’s Rocket Pharmaceuticals RCKT Stock Holding History

HSBC Holdings’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,581
Closed -$48.6K – 3168
2025
Q4 		$48.6K Buy
+13,581
New +$46.5K ﹤0.01% 2865
2025
Q2 		– Sell
-10,583
Closed -$69.1K – 3205
2025
Q1 		$69.1K Buy
+10,583
New +$105K ﹤0.01% 2865
2024
Q2 		– Sell
-8,048
Closed -$217K – 3131
2024
Q1 		$217K Buy
+8,048
New +$229K ﹤0.01% 2647
2022
Q4 		– Sell
-11,412
Closed -$177K – 3167
2022
Q3 		$177K Buy
+11,412
New +$178K ﹤0.01% 2657
2019
Q4 		– Sell
-10,687
Closed -$125K – 3159
2019
Q3 		$125K Buy
+10,687
New +$133K ﹤0.01% 2957

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HSBC Holdings's RCKT Position: Q1 2026 in Review

HSBC Holdings sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 13,581 shares — an estimated $48.6K sold.

HSBC Holdings first reported a position in RCKT in Q3 2019 and held it in 5 quarters. The position peaked at $217K in Q1 2024. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • HSBC Holdings reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 13,581 Rocket Pharmaceuticals shares in Q1 2026, an estimated $48.6K.
  • HSBC Holdings first reported a position in Rocket Pharmaceuticals in Q3 2019 and held it in 5 quarters.
  • HSBC Holdings's Rocket Pharmaceuticals position peaked at $217K in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.